Publications by authors named "Daniel Deaver"

Claim this Profile
S
Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosis.
Orion P Keifer, Juanmarco Gutierrez, Mark T Butt, Sarah D Cramer, Raymond Bartus, Daniel Deaver

PLoS One· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Samidorphan, an opioid receptor antagonist, attenuates drug-induced increases in extracellular dopamine concentrations and drug self-administration in male Wistar rats.
Jacobi I Cunningham, Mark S Todtenkopf, Reginald L Dean, Marc R Azar, George F Koob, Daniel R Deaver

Pharmacol Biochem Behav· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic administration of buprenorphine in combination with samidorphan produces sustained effects in olfactory bulbectomised rats and Wistar-Kyoto rats.
Nikita N Burke, Yan Li, Daniel R Deaver, David P Finn, Michelle Roche

J Psychopharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates.
Jacobi I Cunningham, David J Eyerman, Mark S Todtenkopf, Reginald L Dean, Daniel R Deaver

J Psychopharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat.
Karen L Smith, Jacobi I Cunningham, David J Eyerman, Reginald L Dean, Daniel R Deaver

Neuropharmacology· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats.
Nikita N Burke, Mehnaz Ferdousi, Daniel R Deaver, David P Finn, Michelle Roche

Neuropharmacology· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder.
Jean M Bidlack, Brian I Knapp, Daniel R Deaver, Margarita Plotnikava, Derrick Arnelle

J Pharmacol Exp Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of samidorphan, a μ-opioid antagonist, in a drug discrimination assay in rats.
Mario P Sgro, Deah L Modlin, Daniel R Deaver, Mary J Kallman, Mark S Todtenkopf

Drug Dev Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model.
Charlotte K Callaghan, Jennifer Rouine, Reginald L Dean, Brian I Knapp, Jean M Bidlack, Daniel R Deaver

Brain Behav Immun· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences and similarities in depressive- and anxiety-like behaviour in the Wistar-Kyoto rat.
Nikita N Burke, Jonathan Coppinger, Daniel R Deaver, Michelle Roche, David P Finn

Physiol Behav· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets.
Anton Bespalov, Thomas Steckler, Bruce Altevogt, Elena Koustova, Phil Skolnick, Daniel Deaver

Nat Rev Drug Discov· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational potential of naloxone and naltrexone as TLR4 antagonists.
Phil Skolnick, Hirsch Davis, Derrick Arnelle, Daniel Deaver

Trends Pharmacol Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting atypical antipsychotics: characterization of the local tissue response.
Sara Montminy Paquette, Had Dawit, Magali B Hickey, Elaine Merisko-Liversidge, Orn Almarsson, Daniel R Deaver

Pharm Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of extended-release injectable naltrexone on self-injurious behavior in rhesus macaques (Macaca mulatta).
Doty J Kempf, Kate C Baker, Margaret H Gilbert, James L Blanchard, Reginald L Dean, Daniel R Deaver

Comp Med· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats.
Reginald L Dean, David Eyerman, Mark S Todtenkopf, Ryan Z Turncliff, Jean M Bidlack, Daniel R Deaver

Pharmacol Biochem Behav· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys.
Corina Jimenez-Gomez, Gail Winger, Reginald L Dean, Daniel R Deaver, James H Woods

Behav Pharmacol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
Mark S Todtenkopf, Krystal S O'Neill, Kristina Kriksciukaite, Ryan Z Turncliff, Reginald L Dean, Daniel R Deaver

Addict Biol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone.
Reginald L Dean, Mark S Todtenkopf, Daniel R Deaver, Mahin F Arastu, Nan Dong

Pharmacol Biochem Behav· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 6-month inhalation study to characterize the toxicity, pharmacokinetics, and pharmacodynamics of human insulin inhalation powder (HIIP) in beagle dogs.
Andrew Vick, Ronald Wolff, Alan Koester, Rachel Reams, Daniel R Deaver

J Aerosol Med· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis